Navigation Links
Children's Sugar-Free, Dye-Free ZYRTEC(R) Allergy Syrup Now Available
Date:1/27/2009

Allergy Product in New Bubble Gum Flavor for Ages Two Years and Older

FT. WASHINGTON, Pa., Jan. 27 /PRNewswire/ -- McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., today announced the availability of Children's ZYRTEC(R) Allergy Bubble Gum Syrup, a new sugar-free, dye-free bubble gum flavor product used to treat perennial and seasonal allergic rhinitis, also known as upper respiratory allergies, in children ages two years and older. Children's ZYRTEC(R) Allergy Bubble Gum Syrup relieves kids' indoor and outdoor allergy symptoms. The new children's product is available in original prescription strength without a prescription in local retail stores starting today.

"The new sugar-free, dye-free children's allergy product offers the allergy relief of ZYRTEC(R) that parents have relied on for years, but without the addition of corn syrup or food dyes," said Rohinish Hooda, Vice President of Marketing, Upper Respiratory, McNeil Consumer Healthcare. "Children's ZYRTEC(R) Allergy Bubble Gum Syrup is an important addition to our pediatric portfolio to help parents manage their child's indoor and outdoor allergy symptoms."

Children's ZYRTEC(R) Allergy Bubble Gum Syrup, which is available in a convenient plastic bottle, received approval from the Food and Drug Administration in August 2008 to treat indoor and outdoor allergy symptoms for 24 hours. ZYRTEC(R) has a variety of products in different flavors and forms to help relieve children's allergy symptoms. These products are available in the original prescription strength without a prescription and include Children's ZYRTEC(R) Allergy Grape Syrup and sugar-free, dye-free Children's ZYRTEC(R) Allergy Bubble Gum Syrup for ages two years and older, as well as Children's ZYRTEC(R) Allergy Chewables for ages six years and older. ZYRTEC(R) also offers Children's ZYRTEC(R) Hives Relief Syrup for ages six years and older. For more information on Children's ZYRTEC(R) Allergy Bubble Gum Syrup and the portfolio of ZYRTEC(R) allergy products for adults and children, visit www.zyrtec.com.

About Allergies

More than 36 million Americans suffer from indoor and outdoor allergic rhinitis, also known as upper respiratory allergies. Up to 40 percent of children are affected by allergic rhinitis. In fact, on any given day, an estimated 10,000 American children miss school because of allergic rhinitis, for an annual total of two million lost school days. Allergies are caused when a person's immune system overreacts to normally harmless substances. These substances are often referred to as triggers. People can encounter indoor and outdoor allergy triggers anytime throughout the year that can lead to allergy symptoms. For children with allergies, the change of the seasons, sports, and even the school building itself can trigger symptoms like sneezing, runny nose and itchy-watery eyes.

About ZYRTEC(R)

ZYRTEC(R) is an antihistamine that helps block the action of histamine in the body. ZYRTEC(R) helps provide 24 hour relief of indoor and outdoor upper respiratory allergy symptoms including symptoms of sneezing, runny nose, and itchy-watery eyes. These symptoms can be caused by allergy triggers such as dust, mold and pet dander, tree pollen, weeds and grasses. ZYRTEC(R) offers a full line of products for adults, including ZYRTEC(R) tablets and ZYRTEC-D(R), as well as children. For more information about full line of ZYRTEC(R) products, visit www.zyrtec.com.

About McNeil Consumer Healthcare

McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., a subsidiary of Johnson & Johnson, markets a broad range of well-known and trusted over-the-counter (OTC) products. McNeil Consumer Healthcare is most widely recognized for the complete line of TYLENOL(R) acetaminophen products, the leading pain reliever brand in the adult and pediatric categories. The TYLENOL(R) product line consists of hundreds of products across a variety of pain categories including: arthritis pain, pain with accompanying sleeplessness and upper respiratory. Other McNeil Consumer Healthcare brands include BENADRYL(R) allergy medicine; IMODIUM(R) A-D anti-diarrheal; MOTRIN(R) IB; PediaCare(R) upper respiratory medicines for children; ROLAIDS(R) antacid products; ST. JOSEPH(R) Adult Regimen Aspirin; and SUDAFED(R) and SUDAFED PE(R) nasal decongestants.

    CONTACTS:
    Teresa Panas                     Kathryn Ritzinger
    McNeil Consumer Healthcare       Cohn & Wolfe
    (908) 904-3198                   (212) 537-8217
    tpanas@its.jnj.com               kathryn.ritzinger@cohnwolfe.com


'/>"/>
SOURCE McNeil Consumer Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nautica Malibu Triathlon Presented by Toyota Raises $718,000 for Childrens Hospital Los Angeles Pediatric Cancer Research
2. Childrens Hospital Los Angeles Turns Off the Tap With Green Earth Waterless Carwash
3. Siegel+Gale Designs New HOPE Portal for Childrens Hospital Los Angeles
4. Jessica Biel and Make The Difference Network Bring Holiday Cheer to Childrens Hospital Los Angeles
5. National Childrens Study Begins Recruiting
6. FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
8. Pollen, Fruits, Veggies Help Trigger Oral Allergy Syndrome
9. Cell that triggers symptoms in allergy attacks can also limit damage, Stanford researchers find
10. Clean to Ease Allergy and Asthma Symptoms
11. Mount Sinai & ENT and Allergy Associates, LLP affiliate to fight cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... ... 24, 2016 , ... EB Medicine presented its first-ever “Issue ... conference in Ponte Vedra Beach, FL. The awards honor the outstanding work of ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)...  In a startling report released today, National Safety Council ... a comprehensive, proven plan to eliminate prescription opioid overdoses. ... states are tackling the worst drug crisis in recorded U.S. history, ... Kentucky , New Mexico , ... the 28 failing states, three – Michigan , ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
Breaking Medicine Technology: